CLINICAL_TRIALS
trial_result
· 2021-06-29
Clinical Trial Update: Safety Study of OPC-12759 Ophthalmic Solution [Phase 1]
Summary
Phase 1 safety study of OPC-12759 ophthalmic solution for dry eye syndromes has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 1 | Status: COMPLETED | Results posted: 2021-06-29